Smeland S - Search Results

1

Transcriptomic subtyping of malignant peripheral nerve sheath tumours highlights immune signatures, genomic profiles, patient survival and therapeutic targets.

Høland M, Berg KCG, Eilertsen IA, Bjerkehagen B, Kolberg M, Boye K, Lingjærde OC, Guren TK, Mandahl N, van den Berg E, Palmerini E, Smeland S, Picci P, Mertens F, Sveen A, Lothe RA. Høland M, et al. Among authors: smeland s. EBioMedicine. 2023 Nov;97:104829. doi: 10.1016/j.ebiom.2023.104829. Epub 2023 Oct 12. EBioMedicine. 2023. PMID: 37837931 Free PMC article.

2

Methods for prospective studies of adverse effects as applied to prostate cancer patients treated with surgery or radiotherapy without hormones.

Stensvold A, Dahl AA, Brennhovd B, Cvancarova M, Fosså SD, Lilleby W, Axcrona K, Smeland S. Stensvold A, et al. Among authors: smeland s. Prostate. 2012 May 1;72(6):668-76. doi: 10.1002/pros.21470. Epub 2011 Aug 1. Prostate. 2012. PMID: 21809351

3

Total antioxidant intake in relation to prostate cancer incidence in the Health Professionals Follow-Up Study.

Russnes KM, Wilson KM, Epstein MM, Kasperzyk JL, Stampfer MJ, Kenfield SA, Smeland S, Blomhoff R, Giovannucci EL, Willett WC, Mucci LA. Russnes KM, et al. Among authors: smeland s. Int J Cancer. 2014 Mar 1;134(5):1156-65. doi: 10.1002/ijc.28438. Epub 2013 Nov 11. Int J Cancer. 2014. PMID: 23959920 Free PMC article.

4

Simultaneous quantification of reduced and oxidized glutathione in plasma using a two-dimensional chromatographic system with parallel porous graphitized carbon columns coupled with fluorescence and coulometric electrochemical detection.

Sakhi AK, Russnes KM, Smeland S, Blomhoff R, Gundersen TE. Sakhi AK, et al. Among authors: smeland s. J Chromatogr A. 2006 Feb 3;1104(1-2):179-89. doi: 10.1016/j.chroma.2005.11.129. J Chromatogr A. 2006. PMID: 16376913

5

[Can physical activity prevent cancer?].

Thune I, Smeland S. Thune I, et al. Among authors: smeland s. Tidsskr Nor Laegeforen. 2000 Nov 10;120(27):3296-301. Tidsskr Nor Laegeforen. 2000. PMID: 11187174 Review. Norwegian.

6

[Rehabilitation after cancer].

Fosså SD, Dahl AA, Smeland S, Thorsen L, Loge JH. Fosså SD, et al. Among authors: smeland s. Tidsskr Nor Laegeforen. 2008 Nov 20;128(22):2615-6. Tidsskr Nor Laegeforen. 2008. PMID: 19023358 Free article. Norwegian. No abstract available.

7

The Scandinavian Sarcoma Group Register 1986-2001.

Bauer HC, Alvegård TA, Berlin O, Erlanson M, Kalén A, Lindholm P, Gustafson P, Smeland S, Trovik CS. Bauer HC, et al. Among authors: smeland s. Acta Orthop Scand Suppl. 2004 Apr;75(311):8-10. doi: 10.1080/00016470410001708260. Acta Orthop Scand Suppl. 2004. PMID: 15188659 No abstract available.

8

[Effects of public initiatives aimed at reducing neural tube defects with folic acid supplementation].

Staff AC, Løken EB, Holven K, Sygnestveit K, Vollset SE, Smeland S. Staff AC, et al. Among authors: smeland s. Tidsskr Nor Laegeforen. 2005 Feb 17;125(4):435-7. Tidsskr Nor Laegeforen. 2005. PMID: 15742016 Free article. Review. Norwegian.

9

The role of interferons in the treatment of osteosarcoma.

Whelan J, Patterson D, Perisoglou M, Bielack S, Marina N, Smeland S, Bernstein M. Whelan J, et al. Among authors: smeland s. Pediatr Blood Cancer. 2010 Mar;54(3):350-4. doi: 10.1002/pbc.22136. Pediatr Blood Cancer. 2010. PMID: 19902521 Review.

10

Interferon-alpha as the only adjuvant treatment in high-grade osteosarcoma: long term results of the Karolinska Hospital series.

Müller CR, Smeland S, Bauer HC, Saeter G, Strander H. Müller CR, et al. Among authors: smeland s. Acta Oncol. 2005;44(5):475-80. doi: 10.1080/02841860510029978. Acta Oncol. 2005. PMID: 16118081

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

106 results

Search Page